Moxisylyte [moxisylyt]
- Terms
-
moxisylyt-hydrochlorid
thymoxamin
-
Acetoxythymoxamine
Carlytène
Icavex
Moxisylyte Hydrochloride
Thymoxamine
Thymoxyalcylamine
An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
- DUI
- D013948 MeSH Browser
- CUI
- M0021466
- CAS
- Phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester)
- Previous indexing
- Sympatholytics (1966-1971); Carvacrol (1966-1971)
- History note
- 93; was THYMOXAMINE 1972-92 (Prov 1972); MOXISYLYTE was see THYMOXAMINE 1976-92
- Online note
- use MOXISYLYTE to search THYMOXAMINE 1972-92 (as Prov 1972)
- Public note
- 93; was THYMOXAMINE 1972-92; MOXISYLYTE was see THYMOXAMINE 1976-92
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine